The Library
Browse by Warwick Author
 | Up a level |
Jump to: Assurance Medical Society UK | Boehringer Ingelheim Pharmaceuticals | Bristol-Myers Squibb Company | Daiichi-Sankyo UK | Diabetes UK | Eli Lilly and Company | J P Moulton Charitable Foundation | Merck Sharp & Dohme | Novo Nordisk | Pfizer Inc. | Pfizer Ltd. | Produits Roche S.A. | Sanofi aventis (Firm) | Schering-Plough Corporation | Servier Laboratories Ltd. | Solvay Health Care | Takeda UK (Firm)
Number of items: 17.
Assurance Medical Society UK
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Boehringer Ingelheim Pharmaceuticals
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Bristol-Myers Squibb Company
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Daiichi-Sankyo UK
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Diabetes UK
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Eli Lilly and Company
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
J P Moulton Charitable Foundation
Patel, Jaimin M., Snaith, Catherine, Thickett, David R., Linhartova, Lucie, Melody, Teresa, Hawkey, P. M., Barnett, A. H., Jones, Alan, Hong, Tan, Cooke, Matthew, Perkins, Gavin D. and Smith, F. Gao (2012) Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial). Critical Care, Volume 16 (Number 6). Article number R231. doi:10.1186/cc11895
Merck Sharp & Dohme
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Novo Nordisk
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Pfizer Inc.
Patel, Jaimin M., Snaith, Catherine, Thickett, David R., Linhartova, Lucie, Melody, Teresa, Hawkey, P. M., Barnett, A. H., Jones, Alan, Hong, Tan, Cooke, Matthew, Perkins, Gavin D. and Smith, F. Gao (2012) Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial). Critical Care, Volume 16 (Number 6). Article number R231. doi:10.1186/cc11895
Pfizer Ltd.
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Produits Roche S.A.
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Sanofi aventis (Firm)
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Schering-Plough Corporation
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Servier Laboratories Ltd.
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Solvay Health Care
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
Takeda UK (Firm)
Rees, Simon D., Hydrie, M. Z. I., Shera, A. S., Kumar, Sudhesh, O'Hare, J. Paul, Barnett, A. H., Basit, A. and Kelly, M. Ann (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, Volume 54 (Number 6). pp. 1368-1374. doi:10.1007/s00125-011-2063-2
This list was generated on Mon Jun 27 05:41:49 2022 BST.
